Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Conran

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|July 14, 2022
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS studyNicola Conran, Claudia de Alvarenga Maximo, Thais Oliveira, et al.
Cytokine|June 14, 2017
Association of plasma CD40L with acute chest syndrome in sickle cell anemiaVanessa Tonin Garrido, Laura Sonzogni, Siana Nkya Mtatiro, et al.
Experimental Hematology|December 3, 2014
In vitro microfluidic model for the study of vaso-occlusive processesVenina M Dominical, Daiana M Vital, Frank O'Dowd, et al.
Acta Haematologica|April 2, 2005
Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectinAngêla Assis, Nicola Conran, Andreia A Canalli, et al.
British Journal of Haematology|February 27, 2004
Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patientsNicola Conran, Camila Oresco-Santos, Heloisa C Acosta, et al.
European Journal of Haematology|August 8, 2007
Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell diseaseAndreia A Canalli, Carla F Franco-Penteado, Fabiola Traina, et al.
Blood|July 27, 2012
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceCamila Bononi Almeida, Christoph Scheiermann, Jung-Eun Jang, et al.
British Journal of Haematology|February 9, 2010
Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activityRenata Proença-Ferreira, Carla F Franco-Penteado, Fabiola Traina, et al.
British Journal of Haematology|June 20, 2008
High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophilsCamila Bononi Almeida, Fabiola Traina, Carolina Lanaro, et al.
European Journal of Haematology|February 23, 2007
Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive propertiesSheley Gambero, Andreia A Canalli, Fabiola Traina, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|July 14, 2022
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS studyNicola Conran, Claudia de Alvarenga Maximo, Thais Oliveira, et al.
Cytokine|June 14, 2017
Association of plasma CD40L with acute chest syndrome in sickle cell anemiaVanessa Tonin Garrido, Laura Sonzogni, Siana Nkya Mtatiro, et al.
Experimental Hematology|December 3, 2014
In vitro microfluidic model for the study of vaso-occlusive processesVenina M Dominical, Daiana M Vital, Frank O'Dowd, et al.
Acta Haematologica|April 2, 2005
Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectinAngêla Assis, Nicola Conran, Andreia A Canalli, et al.
British Journal of Haematology|February 27, 2004
Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patientsNicola Conran, Camila Oresco-Santos, Heloisa C Acosta, et al.
European Journal of Haematology|August 8, 2007
Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell diseaseAndreia A Canalli, Carla F Franco-Penteado, Fabiola Traina, et al.
Blood|July 27, 2012
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceCamila Bononi Almeida, Christoph Scheiermann, Jung-Eun Jang, et al.
British Journal of Haematology|February 9, 2010
Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activityRenata Proença-Ferreira, Carla F Franco-Penteado, Fabiola Traina, et al.
British Journal of Haematology|June 20, 2008
High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophilsCamila Bononi Almeida, Fabiola Traina, Carolina Lanaro, et al.
European Journal of Haematology|February 23, 2007
Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive propertiesSheley Gambero, Andreia A Canalli, Fabiola Traina, et al.
Pageof 9